Low and High Doses of Prophylactic Vitamin D in Prevention of Osteopenia of Prematurity
NCT ID: NCT04768439
Last Updated: 2021-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
80 participants
INTERVENTIONAL
2020-08-10
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Different Doses of Vitamin D in Preterm Infants
NCT03889717
Vitamin D Status and the Adequacy of Vitamin D Intake in Early Preterm Infants
NCT01793402
Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
NCT01469650
The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.
NCT06199102
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
NCT04244474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
200 IU/d vitamin D
Patients will receive low-dose vitamin D (200 IU/d)
Low Dose Vitamin D
Patients will receive a 200 IU/d vitamin D since they tolerate full enteral nutrition.
1600 IU/d vitamin D
Patients will receive high-dose vitamin D (1600 IU/d)
High Dose Vitamin D
Patients will receive 1600 IU/d vitamin D since they tolerate full enteral nutrition.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Dose Vitamin D
Patients will receive a 200 IU/d vitamin D since they tolerate full enteral nutrition.
High Dose Vitamin D
Patients will receive 1600 IU/d vitamin D since they tolerate full enteral nutrition.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Being NPO (nothing per oral) for more than 2 wks
* Gestational age more than 32 weeks
* Birth weight more than 1500 grams
1 Day
2 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Mohamed Farag
Lecturer in Pediatrics, Faculty of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marwa M Farrag, PhD
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine, Alexandria University, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00007555-00015712
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.